Bausch Health stock soars 8.6% premarket on news of patent settlement
Bausch Health stock soars 8.6% premarket on news of patent settlement MarketWatch Bausch Health resolves Xifaxan patent dispute with Actavis Seeking Alpha Bausch Health (BHC) Stock: Flying On Patent Settlement CNA Finance Full coverage